Frederick G. Vogt - 16 Jan 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Interim CEO & General Counsel
Signature
/s/ Frederick G. Vogt
Issuer symbol
IOVA
Transactions as of
16 Jan 2024
Net transactions value
-$54,656
Form type
4
Filing time
18 Jan 2024, 18:09:35 UTC
Previous filing
18 Oct 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $0 +20,834 +25% $0.000000 105,668 16 Jan 2024 Direct F1
transaction IOVA Common Stock Tax liability $54,656 -6,530 -6.2% $8.37 99,138 16 Jan 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Restricted Stock Units Options Exercise $0 -20,834 -20% $0.000000 83,338 16 Jan 2024 Common stock 20,834 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
F3 Represents common stock remaining after deducting the common stock withheld for taxes.
F4 Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F5 The remaining RSUs will vest in equal quarterly installments.